Skip to main content
Book cover

Tumors of the Central Nervous System, Volume 1

Gliomas: Glioblastoma (Part 1)

  • Book
  • © 2011

Overview

  • Targeted therapy determined by molecular genetics is emphasized
  • Role of molecular genetics in the CNS cancer development is discussed
  • Advantages and limitations of biomarkers in tumor detection and diagnosis are detailed
  • The role of translational medicine is emphasized (bench to bed)
  • Can be used as an outside reading to obtain additional information at seminars and conferences in the medical field
  • Teachers in medicine would be interested

Part of the book series: Tumors of the Central Nervous System (TCNS, volume 1)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (42 chapters)

  1. Introduction

  2. Biomarkers and Diagnosis

Keywords

About this book

The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.

Reviews

From the reviews:

“This is an outstanding book on every molecular mediator of cancer stem cells, angiogenesis, surface markers, and CAD mediators of oncogenesis in the brain. … This is a very good book for neuropathologists and neurosurgeons.” (Joseph J. Grenier, Amazon.com, June, 2014)

Editors and Affiliations

  • Dept. Biological Sciences, Kean University, Union, USA

    M. A. Hayat

Bibliographic Information

  • Book Title: Tumors of the Central Nervous System, Volume 1

  • Book Subtitle: Gliomas: Glioblastoma (Part 1)

  • Editors: M. A. Hayat

  • Series Title: Tumors of the Central Nervous System

  • DOI: https://doi.org/10.1007/978-94-007-0344-5

  • Publisher: Springer Dordrecht

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media B.V. 2011

  • Hardcover ISBN: 978-94-007-0343-8Published: 23 March 2011

  • Softcover ISBN: 978-94-007-3558-3Published: 23 April 2013

  • eBook ISBN: 978-94-007-0344-5Published: 23 March 2011

  • Series ISSN: 2215-096X

  • Series E-ISSN: 2215-0978

  • Edition Number: 1

  • Number of Pages: XXII, 434

  • Topics: Cancer Research, Neuroradiology, Neurosurgery, Oncology, Pathology, Surgery

Publish with us